New cytokine-dependent acute myeloid leukemia cell line MUTZ-11 with disomic chromosome rearrangement t(16;17)

Leukemia Research

Volumn 28, Issue 5, 2004, Pages 509-515

  Hu, Zhen Bo ^a   Quentmeier, Hilmar ^b   Meyer, Corinna ^b   Kaufmann, Maren ^b   MacLeod, Roderick A F ^b   Drexler, Hans G ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

AML; Cell lines; Cytokines; Leukemia

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; BIOLOGICAL MARKER; CD123 ANTIGEN; CD15 ANTIGEN; CD33 ANTIGEN; CD4 ANTIGEN; CD7 ANTIGEN; CHLORDANE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; LYMPHOTOXIN; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; B LYMPHOCYTE; BLOOD; CASE REPORT; CELL GROWTH; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; DISOMY; DNA FINGERPRINTING; FEMALE; FLOW CYTOMETRY; GROWTH STIMULATION; HUMAN; HUMAN CELL; KARYOTYPE 46,XX; LEUKEMIA CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; T LYMPHOCYTE;

CELL DIVISION; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 17; CYTOKINES; FEMALE; FMS-LIKE TYROSINE KINASE 3; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; TRANSLOCATION, GENETIC;

EID: 1842611808     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.09.013     Document Type: Article

References (20)

1. Drexler HG, Gignac SM, Minowada J. Hematopoietic cell lines. In: Hay RJ, Gazdar R, Park JG, editors. Atlas of human tumor cell lines. Orlando: Academic Press; 1994. p. 213-50.
2. Drexler HG, editor. The leukemia-lymphoma cell line factsbook. San Diego: Academic Press; 2000.
3. Drexler H.G., MacLeod R.A.F., Borkhardt A., Janssen J.W.G. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines. Leukemia. 9:1995;480-500.
4. Drexler H.G., Matsuo Y., MacLeod R.A.F. Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research. Leuk. Res. 24:2000;881-911.
5. Quentmeier H., Zaborski M., Drexler H.G. The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines. Leuk. Res. 21:1997;343-350.
6. Drexler H.G., Matsuo Y. Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia. 13:1999;835-842.
7. Drexler HG, Uphoff CC. Contamination of cell cultures, mycoplasma. In: Spier E, Griffiths B, Scragg AH, editors. The encyclopedia of cell technology. New York: Wiley; 2000. p. 609-27.
8. Drexler H.G., Zaborski M., Quentmeier H. Cytokine response profiles of human myeloid factor-dependent leukemia cell lines. Leukemia. 11:1997;701-708.
9. Drexler H.G., Dirks W.G., MacLeod R.A.F. False human hematopoietic cell lines: cross-contaminations and misinterpretations. Leukemia. 13:1999;1601-1607.
10. Drexler HG, Dirks WG, MacLeod RAF, Quentmeier H, Steube KG, Uphoff CC, editors. DSMZ catalogue of human and animal cell lines. 8th ed. Germany: Braunschweig; 2001.
11. Hu Z.B., Ma W., Zaborski M., MacLeod R.A.F., Quentmeier H., Drexler H.G. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3. Leukemia. 10:1996;1025-1040.
12. Matsuo Y., MacLeod R.A.F., Uphoff C.C., Drexler H.G., Nishizaki C., Katayama Y.et al. Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22;p23). Leukemia. 11:1997;1469-1477.
13. MacLeod RAF, Drexler HG. Cytogenetic characterization of tumor cell lines. In: Langdon S, editor. Cancer cell culture. Methods and protocols. Totowa, NY: Humana Press; 2003. p. 57-78.
14. Morerio C., Russo I., Rosanda C., Rapella A., Leszl A., Basso G.et al. 17q21-qter trisomy is an indicator of poor prognosis in acute myelogenous leukemia. Cancer Genet. Cytogenet. 124:2001;12-15.
15. Brunning RD, Matutes E, Harris NL, Flandrin G, Vardiman J, Bennett J, et al. Acute myeloid leukemia. In: Jaffe ES, Harris NL, Stein H, Vardiman J, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 75-108.
16. Löwenberg B. What has genetics to offer to the management of AML? Hematol. J. 4(Suppl 3):2003;146-148.
17. Schnittger S., Kinkelin U., Schoch C., Heinecke A., Haase D., Haferlach T.et al. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia. 14:2000;796-804.
18. Quentmeier H., Reinhardt J., Zaborski M., Drexler H.G. FLT3 mutations in acute myeloid leukemia cell lines. Leukemia. 17:2003;120-124.
19. Quentmeier H., Reinhardt J., Zaborski M., Drexler H.G. MLL partial tandem duplications in acute leukemia cell lines. Leukemia. 17:2003;980-981.
20. Jamal R., Taketani T., Taki T., Bessho F., Hongo T., Hamaguchi H.et al. Coduplication of the MLL and FLT3 genes in patients with acute myeloid leukemia. Genes Chromosomes Cancer. 31:2001;187-190.